HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


U.S. Expects “American Standards” From Food, Drug Pacts With China

This article was originally published in The Tan Sheet

Executive Summary

Agreements reached Dec. 11 will ensure that Chinese food and drug products imported to the U.S. are produced "in accordance with American standards of quality and safety," according to Health and Human Services Secretary Michael Leavitt

You may also be interested in...

China Taking Regulatory Route To Tighten Oversight Of Health Care Sector

China aims to upgrade supervision of its entire health care sector with an array of regulatory changes for pharmaceuticals and medical devices likely this year, including good manufacturing practice guidelines, according to a leading lawyer in the area of China's life sciences-related issues and legislation

FDA, OTC Industry Look To Protect Supply Chain Security From Global Threats

FDA and the pharmaceutical industry have some catching up to do to mitigate the import safety and counterfeiting risks amplified by the globalization of supply chains, says the agency's policy chief

China Changes SFDA, May Look At U.S. Supplement Regulation Model – NPA

The reorganization of China's State Food and Drug Administration should create a "really good opportunity" for the dietary supplement industry, says Jeff Crowther, director of the Natural Products Association's office in China

Related Content


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts